✦ LIBER ✦

Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: Evaluation of transdermal absorption, safety, and pharmacological effects after application in rats

✍ Scribed by Katsumi, Hidemasa (author);Liu, Shu (author);Tanaka, Yutaro (author);Hitomi, Kaori (author);Hayashi, Rie (author);Hirai, Yuka (author);Kusamori, Kosuke (author);Quan, Ying Shu (author);Kamiyama, Fumio (author);Sakane, Toshiyasu (author);Yamamoto, Akira (author)

Book ID: 112134540
Publisher: John Wiley and Sons Inc.
Year: 2012
Tongue: English
Weight: 360 KB
Volume: 101
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.23136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of a novel self-dissolving m

Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: Evaluation of transdermal absorption, safety, and pharmacological effects after application in rats

✍ Katsumi, Hidemasa (author);Liu, Shu (author);Tanaka, Yutaro (author);Hitomi, Kao 📂 Article 📅 2012 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 360 KB

Development of polyethylene glycol-conju

Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: Evaluation of absorption, safety, and effects after intrapulmonary administration in rats

✍ Hidemasa Katsumi; Miki Takashima; Jun-Ichi Sano; Kazushi Nishiyama; Noriko Kitam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Bisphosphonates are widely used for the treatment of bone diseases, including hypercalcemia and osteoporosis. However, the bioavailability (BA) of orally administered bisphosphonates is low, at approximately 0.9%-1.8%. In addition, the oral administration of bisphosphonates is associated with mucosa